Persistent URL of this record https://hdl.handle.net/1887/3515278
Documents
-
- Download
- s13063-022-06897-3
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
- All authors
- Nickerson, P.W.; Bohmig, G.A.; Chadban, S.; Kumar, D.; Mannon, R.B.; Gelder, T. van; Lee, J.C.; Adler, S.; Chong, E.; Djamali, A.
- Date
- 2022-12-22
- Journal
- Trials
- Volume
- 23
- Issue
- 1